It is estimated that at least 700,000 people die every year from the infections caused by antibiotic resistant bacteria. If no action is taken the death toll may reach 10 million a year by 2050. It is more than the number of people currently dying from road traffic accidents and cancer together. Antimicrobial resistance (AMR) is the ability of a microorganism (like bacteria, viruses, and some parasites) to stop an antimicrobial (such as antibiotics, antivirals and antimalarials) from working against it. As a result, standard treatments become ineffective, meaning infections persist and may spread to others. Physicians sound alarm over drug resistance The terrifying prospect that even routine operations will be impossible to perform has been raised by experts alarmed by the rise of drug-resistant genes. Currently, the antimicrobial susceptibility test, the so called antibiogram, requires growing a culture for 1-2 days in order to to identify the pathogen. The precise timescale depends on the type of bacteria. After this, an additional 12–24 hours are needed to conduct an antibiotic sensitivity screen. In the case of slow growing bacteria, e.g. M. tuberculosis, such a test may take up a full month to complete. Resistell has developed a patented solution to screen for phenotypic AMRs. The technology detects microbial vibrations using micrometer scale cantilevers. These nanomotion antibiograms deviver reliable results within 2 hours as opposed to days when using classic antibiotic suscebptibility tests.